Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study | MicrobiomeTrials← Back to trialsNCT04338048
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
RecruitingOBSERVATIONAL
Trial Details
Start: 2019-10-10Est. Completion: 2030-10-30
Enrollment target: 300 participants Locations- Children's National Hospital, Washington D.C., District of Columbia, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cohen Children's Medical Center, New Hyde Park, New York, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Other microbiome trials you might be interested in
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
The purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tol…
Alabaster, United StatesEst. completion Jul 22, 2027
Polycystic Kidney, Autosomal Dominant
Autosomal dominant polycystic kidney disease is the most common genetic cause of kidney failure. The only approved treat…
Feldkirch, AustriaEst. completion May 15, 2030